Fused pentacyclic imidazole derivatives
US-11912721-B2 · Feb 27, 2024 · US
This page is not indexed by search engines while we improve data quality.
Shaw Michael Alan patents
Shaw Michael Alan is listed as an inventor on 14 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Shaw Michael Alan |
| Total patents | 14 |
| First publication | Jun 4, 2015 |
| Latest publication | Feb 27, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Fused Pentacyclic Imidazole Derivatives
US-2021155637-A1 · May 27, 2021 · US
Fused pentacyclic imidazole derivatives
US-10906919-B2 · Feb 2, 2021 · US
Fused Pentacyclic Imidazole Derivatives
US-2019367535-A1 · Dec 5, 2019 · US
Fused pentacyclic imidazole derivatives
US-10202405-B2 · Feb 12, 2019 · US
Fused imidazole and pyrazole derivatives as modulators of TNF activity
US-10004737-B2 · Jun 26, 2018 · US
Fused imidazole and pyrazole derivatives as modulators of TNF activity
US-9868749-B2 · Jan 16, 2018 · US
Fused Pentacyclic Imidazole Derivatives
US-2017305932-A1 · Oct 26, 2017 · US
Fused Imidazole and Pyrazole Derivatives as Modulators of TNF Activity
US-2017128445-A1 · May 11, 2017 · US
TNF -α modulating benzimidazoles
US-9550737-B2 · Jan 24, 2017 · US
Recent patents
Latest publications not already listed above.
Fused Imidazole and Pyrazole Derivatives As Modulators of TNF Activity
US-2016297837-A1 · Oct 13, 2016 · US
Imidazopyridine derivatives as modulators of TNF activity
US-9309243-B2 · Apr 12, 2016 · US
Imidazopyridine Derivatives as Modulators of TNF Activity
US-2015203486-A1 · Jul 23, 2015 · US
TNF -Alpha Modulating Benzimidazoles
US-2015152065-A1 · Jun 4, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ucb Biopharma Sprl | 11 |
| Sanofi Sa | 6 |
| UCB Biopharma SRL | 3 |
| Ucb Biopharma Sprl A Corp | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.